Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
Recommendations for primary prevention in women need to be different.
Hung
Joseph
J
D000367:Age Factors; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D001315:Australia; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods* / Q000592:standards*; D018570:Risk Assessment; D012737:Sex Factors; D016896:Treatment Outcome; D016387:Women's Health
D005343:Fibrinolytic Agents; D001241:Aspirin